VivoSim Labs IncVIVS
Price$0.21

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $112K-22.2% YoYTTM through 30 Jun 2026
Net Income -$12.3MTTM through 30 Jun 2026
Free Cash Flow -$10.1MTTM through 30 Jun 2026

Margins

Current
Operating Margin-10,576.9%
Net Margin-11,016.1%

Returns

-51.1%ROE
-29.0%ROA

Balance Sheet Health

Debt / Equity1.29x
Current Ratio3.25x
Net Debt$1.5M
Cash & Equivalents$1.7M

Quality Metrics

Altman Z-Score-139.01
Piotroski F-Score2 / 9
FCF Margin-9,038.4%

Multi-Year Trend

Revenue
'20'21'22'23'24'25'26
FY2026: $131K
Diluted EPS
'22'23'24'25'26
FY2026: $-5.35

Dividend

No dividend

Capital Allocation

Capex Intensity20.5%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.